Biggest News Aggregation in the World
📰 Current Prescribing News

Page 2 - Current Prescribing News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Current Prescribing. Real-time updates on events, politics, business and more.

Teva Pharmaceutical Industries Limited: Teva and MedinCell Announce FDA Approval of UZEDY (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a Phase 3 clinical trial, UZEDY demonstrated
United States Chechnya And Ingushetiya Christophe Douat Christoph Correll Yael Ashman Nicolas Merigeau Newcap

Innocoll Pharmaceuticals Limited: Innocoll Announces Positive Topline Results For XARACOLL (bupivacaine hydrochloride) implant in a Phase 3 Study to Support Expanded Use

XARACOLL 300mg Dose Cohort Experienced Less Pain and XARACOLL was Generally Well Tolerated with an Adverse Event Profile Comparable to the Current Prescribing Information Innocoll Pharmaceuticals
United Kingdom Kostenloser Wertpapierhandel Blair Hennessy Louis Pascarella Gwendolyn Niebler Innocoll Biotherapeutics Holding

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science